logo
15:58 Feb 25

Biocon Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
395.85
+5.10 (+1.31%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Biocon Ltd. Financials

Biocon Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
395.85
+5.10 (+1.31%)
15:58 Feb 25
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

61/100
Technically Moderately Bullish

Strength

7

Weakness

5

Opportunity

1

Threats

0

4.68 %

ROE %

1.72 %

ROA %

3.73

EPS

180.27

BVPS

6.63 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
7105.8 8184 11174.2 14755.7 15261.7
Operating Expenses +
5453.2 6213.8 8662.5 11457 12095.4
Raw Material
2498.6 2975 3817.2 5754.6 4903.3
Increase Decrease in Cost
-290.1 -256.6 -154.1 -856.7 294.2
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1741 1880.1 2181 2664.1 3144.4
Miscellaneous Expenses
1640.5 1937.5 4070.6 5260.4 5006.7
Operating Profit
1652.6 1970.2 2511.7 3298.7 3166.3
Other Income
254.5 212.7 375.9 865.5 1208.2
Depreciation
715.1 814.2 1113.1 1568.8 1687
Interest
57.7 67.6 419 974.4 897.4
Profit before tax and exceptio..
1134.3 1301.1 1355.5 1621 1790.1
Exceptional Items
12.6 -111.1 -291.4 -11.6 96.5
PBT
1146.9 1190 1064.1 1609.4 1886.6
Provision for Taxation
221.5 211.5 254.1 227.4 457.2
Net Profit
915.7 978.5 810 1382 1429.4
NET Profit after MI
740.5 648.4 462.7 1022.5 1013.3
EPS
6.19 5.42 3.88 8.55 8.46
Operating Profit Margin (%)
23.26 24.07 22.48 22.36 20.75
Net Profit Margin (%)
10.42 7.92 4.14 6.93 6.64

Biocon Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 54.40 54.40 54.40 60.60 60.60 60.60
FII 7.40 6.60 6.00 5.70 5.70 5.90
Public 21.70 22.10 22.90 15.70 15.30 14.50
Others 16.50 16.90 16.70 18.00 18.40 19.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: